Related Experiment Video
Updated: Mar 21, 2026
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Early Dietary Fiber Intake in ICU Patients and Its Associations with Acute Gastrointestinal Injury: A Prospective
Ting Liu1, Hai-Fang Wang2, Xiao-Song Jiang1
1Department of Intensive Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China.
Background:
Insufficient early dietary fiber (DF) supplement may be closely associated with adverse clinical outcomes in critically ill patients.
Objective:
We evaluated the association between the early intake of dietary fiber (DF) and the development of acute gastrointestinal injury (AGI) in ICU patients.
Methods:
A prospective observational study was conducted at the First Affiliated Hospital of Soochow University from April 2021 to March 2023. DF intake was quantified using dietary records, and AGI severity was assessed on day 3 (D3) and day 5 (D5) after ICU admission based on the 2012 ESICM recommendations.
Results:
A total of 184 ICU patients were enrolled. The mean daily DF intake over the first five days was 5.44 ± 4.33 g/day. The cumulative intake reached 11.07 ± 11.60 g by day 3 and 27.21 ± 21.65 g by day 5. The incidence of AGI was 95.6%, 77.7%, and 51.1% on days 1, 3, and 5, respectively. Ordered logistic regression revealed that higher average DF intake in the first three days was independently associated with reduced AGI severity on D3 (OR 0.863, 95% CI: 0.771-0.967, P < 0.05) and D5 (OR 0.823, 95% CI: 0.712-0.952, P < 0.05).
Conclusion:
Higher average DF intake during the first three days following ICU admission may be associated with reduced AGI severity on D3 and D5. Future multi-center, large-sample, randomized controlled studies are needed to confirm the relationship between early DF intake and the severity of AGI.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...